News Daily News DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight Todd Neale February 25, 2019
News Conference News ISC 2019 Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects Todd Neale February 13, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Daily News Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines Todd Neale January 29, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Daily News High Risk of Major Bleeding Observed in Danish A-fib Population on Triple, Dual Antithrombotic Therapy Yael L. Maxwell December 13, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
News Daily News Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes Todd Neale September 13, 2018
News Conference News AHA 2017 Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation Michael O'Riordan November 13, 2017
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016